50
5th Edition – Paris -- June 4-5, 2015

How and why Indian pharma needs to engage with the new millenial doctors and patients

Embed Size (px)

Citation preview

Page 1: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 2: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

IVF SpecialistInformation TherapistAngel Investor

Page 3: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 4: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 5: How and why Indian pharma needs to engage with the new millenial doctors and patients

Today’s Health Care Today’s Health Care SystemSystem

Patient

Health Insurance

Government

Information Overload

Media

The Physician

Page 6: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Unfortunately, while doctors are quite eager to discuss medicine, most are unwilling to talk about the nuts and bolts of practise management

Don’t want to enrich the competition by giving away their “trade secrets” !

We can learn together and help each other

Page 7: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Too many patients- not enough doctors

No trust in the system Pharma seen to be greedy Medical profession seen to be

corrupt Media loves doctor bashing Violence against doctors Government regulations

Page 8: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 9: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Products + services = solutionsHow do we leverage Digital health

Technology to reach outApps ?Patient portals ?Wearables ? IOT ?High tech plus high touch !

Page 10: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Regulatory hurdlesNot a core competenceCorporate inertiaProve ROI ?How do you scale up ?

Page 11: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

MarketingCommunicationsCustomer serviceCorporate social responsibility

Who will pay ?

Page 12: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Innovate and experimentSkunkwork teams – take risks and

allow them to fail. Test. Learn. RepeatLeverage partnershipsTap into early adopters – the

millenial digital doctorsLearn from Healthcare startups

Page 13: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Just a buzzword ?Patient-centric” doesn't mean selling

more product – it means answering a patient's needs above your own.

Page 14: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

We try never to forget that medicine is for the people. It is not for the profits. The profits follow, and if we have remembered that, they have never failed to appear. The better we have remembered it, the larger they have been. — George W(ilhelm) Merck

Address to the Medical College of Virginia, Richmond (1 Dec 1950).

Page 15: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Startups are changing the healthcare ecosystem

Disruption because they are nimble and lean

Challenge the status quo !

Page 16: How and why Indian pharma needs to engage with the new millenial doctors and patients
Page 17: How and why Indian pharma needs to engage with the new millenial doctors and patients
Page 18: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Go to where your customers are !Social media provides great insights

into what people are thinking, feeling and discussing

Page 19: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Amplifies the doctor’s impact and reach Virtual worlds Wisdom of the crowd Push and pull – on your mobile 24/7 convenience Sermo Docplexus Curofy Dailyrounds

Page 20: How and why Indian pharma needs to engage with the new millenial doctors and patients
Page 21: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Feel saferProfessional communityA chance to discuss professional

issues in confidenceAn opportunity to vent

Page 22: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

CME – polish their medical knowledgebase

Keep upto date with medical advances Networking with friends and colleagues Stumped by difficult patients – need

help from other doctors Chance to share your knowledge and

display your expertise Become a thought leader

Page 23: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Complementary skills – marry the best of both worlds !

Pharma + healthcare startups = winning combination !

Great way to get feedback online from lots of doctors

Page 24: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Help patients get better medical care by Promoting SelfCare , so they can do as

much for themselves as they can Helping them with Evidence-Based

Guidelines , so they can ask for the right medical treatment that they need – no more and no less

Helping them with Veto Power, so they can say No to medical care they don’t need

Page 25: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 26: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

BHAGEvery doctor should have their own

websiteValuable digital real estate - direct

source of referralsOnline reputation managementOpenness, trust and tranparencyLocal language

Page 27: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 28: How and why Indian pharma needs to engage with the new millenial doctors and patients
Page 29: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 30: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

For doctors Patient acquisition – direct source of

referrals Create patient educational materials -

spend once, use often Saves administrative hassles No phone tag – email has a much better

signal to noise ratio Become patient centric and empathetic

Page 31: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

For patients Doctor is available and accessible Can doctor shop from home Get second opinions Trusted voice Local language Transparency and openness creates

trust

Page 32: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 33: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 34: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 35: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 36: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 37: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 38: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 39: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 40: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 41: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 42: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 43: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Bought in bulk by by pharma companies

Customised for each individual doctor

Everyone benefits – pharma company, doctor and patient !

Page 44: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 45: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 46: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 47: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 48: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 49: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Page 50: How and why Indian pharma needs to engage with the new millenial doctors and patients

5th Edition – Paris -- June 4-5, 2015

Patients are the practise – everything else is just paper work !